USD 303.32
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 26.09 Billion CHF | 17.09% |
2022 | 22.28 Billion CHF | 30.3% |
2021 | 17.1 Billion CHF | 54.12% |
2020 | 11.09 Billion CHF | -18.09% |
2019 | 13.54 Billion CHF | -15.74% |
2018 | 16.07 Billion CHF | 1.5% |
2017 | 15.83 Billion CHF | -6.79% |
2016 | 16.99 Billion CHF | -0.63% |
2015 | 17.1 Billion CHF | -11.58% |
2014 | 19.34 Billion CHF | 17.77% |
2013 | 16.42 Billion CHF | -28.19% |
2012 | 22.87 Billion CHF | -2.51% |
2011 | 23.45 Billion CHF | -15.79% |
2010 | 27.85 Billion CHF | -22.93% |
2009 | 36.14 Billion CHF | 1116.12% |
2008 | 2.97 Billion CHF | -22.48% |
2007 | 3.83 Billion CHF | -38.15% |
2006 | 6.19 Billion CHF | -33.5% |
2005 | 9.32 Billion CHF | 34.19% |
2004 | 6.94 Billion CHF | -32.2% |
2003 | 10.24 Billion CHF | -27.68% |
2002 | 14.16 Billion CHF | -13.59% |
2001 | 16.39 Billion CHF | 1.41% |
2000 | 16.16 Billion CHF | 1.28% |
1999 | 15.96 Billion CHF | 14.6% |
1998 | 13.92 Billion CHF | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 28.42 Billion CHF | 0.0% |
2024 Q1 | 30.15 Billion CHF | 14.56% |
2023 Q2 | 20.34 Billion CHF | -5.39% |
2023 FY | 26.09 Billion CHF | 17.09% |
2023 Q3 | 26.09 Billion CHF | 28.24% |
2023 Q4 | 26.09 Billion CHF | 0.0% |
2023 Q1 | 21.5 Billion CHF | -3.5% |
2022 Q4 | 22.28 Billion CHF | 0.0% |
2022 FY | 22.28 Billion CHF | 30.3% |
2022 Q1 | 23.68 Billion CHF | 38.5% |
2022 Q2 | 22.36 Billion CHF | -5.56% |
2022 Q3 | 22.28 Billion CHF | -0.39% |
2021 Q4 | 17.1 Billion CHF | 0.0% |
2021 Q3 | 17.1 Billion CHF | 51.54% |
2021 Q2 | 11.28 Billion CHF | -9.79% |
2021 Q1 | 12.51 Billion CHF | 12.74% |
2021 FY | 17.1 Billion CHF | 54.12% |
2020 Q1 | 13.71 Billion CHF | 1.27% |
2020 FY | 11.09 Billion CHF | -18.09% |
2020 Q3 | 11.09 Billion CHF | -11.17% |
2020 Q4 | 11.09 Billion CHF | 0.0% |
2020 Q2 | 12.49 Billion CHF | -8.95% |
2019 Q3 | 13.54 Billion CHF | -12.02% |
2019 Q4 | 13.54 Billion CHF | 0.0% |
2019 FY | 13.54 Billion CHF | -15.74% |
2019 Q2 | 15.39 Billion CHF | -5.96% |
2019 Q1 | 16.37 Billion CHF | 1.85% |
2018 Q1 | 15.97 Billion CHF | 0.86% |
2018 Q3 | 16.07 Billion CHF | 0.64% |
2018 FY | 16.07 Billion CHF | 1.5% |
2018 Q2 | 15.97 Billion CHF | 0.0% |
2018 Q4 | 16.07 Billion CHF | 0.0% |
2017 Q4 | 15.83 Billion CHF | 0.0% |
2017 FY | 15.83 Billion CHF | -6.79% |
2017 Q3 | 15.83 Billion CHF | -5.33% |
2017 Q2 | 16.73 Billion CHF | 0.0% |
2017 Q1 | 16.73 Billion CHF | -1.54% |
2016 Q2 | 16.41 Billion CHF | 0.0% |
2016 Q1 | 16.41 Billion CHF | -4.01% |
2016 Q3 | 16.99 Billion CHF | 3.52% |
2016 Q4 | 16.99 Billion CHF | 0.0% |
2016 FY | 16.99 Billion CHF | -0.63% |
2015 FY | 17.1 Billion CHF | -11.58% |
2015 Q2 | 17.27 Billion CHF | 0.0% |
2015 Q4 | 17.1 Billion CHF | 0.0% |
2015 Q3 | 17.1 Billion CHF | -0.99% |
2015 Q1 | 17.27 Billion CHF | -10.7% |
2014 Q1 | 14.68 Billion CHF | -10.58% |
2014 Q3 | 19.34 Billion CHF | 31.76% |
2014 Q2 | 14.68 Billion CHF | 0.0% |
2014 FY | 19.34 Billion CHF | 17.77% |
2014 Q4 | 19.34 Billion CHF | -0.04% |
2013 FY | 16.42 Billion CHF | -28.19% |
2013 Q2 | 17.78 Billion CHF | 0.0% |
2013 Q4 | 16.42 Billion CHF | -0.01% |
2013 Q3 | 16.42 Billion CHF | -7.63% |
2013 Q1 | 17.78 Billion CHF | -22.26% |
2012 Q4 | 22.87 Billion CHF | 0.0% |
2012 Q2 | 21.15 Billion CHF | 0.0% |
2012 FY | 22.87 Billion CHF | -2.51% |
2011 Q2 | 22.65 Billion CHF | 0.0% |
2011 FY | 23.45 Billion CHF | -15.79% |
2011 Q4 | 23.45 Billion CHF | 0.0% |
2010 FY | 27.85 Billion CHF | -22.93% |
2010 Q2 | 31.45 Billion CHF | 0.0% |
2010 Q4 | 27.85 Billion CHF | 0.0% |
2009 Q4 | 36.14 Billion CHF | 0.0% |
2009 Q2 | 38.33 Billion CHF | 0.0% |
2009 FY | 36.14 Billion CHF | 1116.12% |
2008 Q2 | 3.68 Billion CHF | 0.0% |
2008 FY | 2.97 Billion CHF | -22.48% |
2008 Q4 | 2.97 Billion CHF | 0.0% |
2007 Q2 | 5.34 Billion CHF | 0.0% |
2007 FY | 3.83 Billion CHF | -38.15% |
2007 Q4 | 3.83 Billion CHF | 0.0% |
2006 Q4 | 6.19 Billion CHF | 0.0% |
2006 FY | 6.19 Billion CHF | -33.5% |
2005 FY | 9.32 Billion CHF | 34.19% |
2004 FY | 6.94 Billion CHF | -32.2% |
2003 FY | 10.24 Billion CHF | -27.68% |
2002 FY | 14.16 Billion CHF | -13.59% |
2001 FY | 16.39 Billion CHF | 1.41% |
2000 FY | 16.16 Billion CHF | 1.28% |
1999 FY | 15.96 Billion CHF | 14.6% |
1998 FY | 13.92 Billion CHF | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
AstraZeneca PLC | 22.33 Billion USD | -16.825% |
Bristol-Myers Squibb Company PFD CONV 2 | 38.18 Billion USD | 31.669% |
CSPC Pharmaceutical Group Limited | 107.05 Million USD | -24270.902% |
Clarus Therapeutics Holdings, Inc. | - USD | -Infinity% |
Novartis AG | 20.03 Billion USD | -30.234% |
PT Kalbe Farma Tbk. | 19.39 Million USD | -134445.895% |